Journal article
Comparison of Dual-antiplatelet Therapy to Mono-antiplatelet Therapy After Transcatheter Aortic Valve Implantation: Systematic Review and Meta-analysis
Abstract
BACKGROUND: Post-transcatheter aortic valve implantation (TAVI) dual-antiplatelet therapy (DAPT) with acetylsalicylic acid and clopidogrel is common practice to reduce ischemic complications despite the lack of clinical trial evidence demonstrating superiority over mono-antiplatelet therapy (MAPT).
METHODS: A systematic search was conducted to retrieve studies that investigated DAPT vs MAPT in patients who have undergone TAVI. Outcomes of …
Authors
Gandhi S; Schwalm J-DR; Velianou JL; Natarajan MK; Farkouh ME
Journal
Canadian Journal of Cardiology, Vol. 31, No. 6, pp. 775–784
Publisher
Elsevier
Publication Date
6 2015
DOI
10.1016/j.cjca.2015.01.014
ISSN
0828-282X
Associated Experts
Fields of Research (FoR)
Sustainable Development Goals (SDG)
Medical Subject Headings (MeSH)
AgedAged, 80 and overAortic Valve StenosisAspirinClopidogrelDrug Therapy, CombinationFemaleHumansMaleMyocardial InfarctionPlatelet Aggregation InhibitorsPostoperative CarePostoperative ComplicationsPrognosisRandomized Controlled Trials as TopicRisk AssessmentStrokeSurvival AnalysisTiclopidineTranscatheter Aortic Valve ReplacementTreatment OutcomeUltrasonography